Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Machaon who wrote (21543)	5/29/1998 4:42:00 AM
From: Torben Noerup Nielsen	Read Replies (1) \| Respond to of 32384

Bob, >Torben, I thought that you were supposed to be out the door, and on >your way to the airport I was. But I delayed one day; I happen to have one of those nice tickets where you get to sit up front and they can be changed anytime you like :-) Seriously, there was just too much to do. And I needed more time to get my act together! Try going around the world - litterally - in 2 weeks sometime. It takes some organizing. >But...... I wonder........ If Panretin is effective against AIDS KS, >what are the odds that it would also be as effective against the >other types of skin cancer? Well, I wonder too. But I'm sure it will get tried. Note that there are also several other related compounds in the pipeline. With real use on patients at different stages of the disease, a better picture should emerge. And now I have to get back to work so I can get out of here :-( And I will respond on the ADPT thread when I get home again in a few weeks. After visiting Tokyo, Frankfurt, Copenhagen, Tromso and San Francisco! Cheers, Torben